Breaking Barriers in Nanomedicine with Priya Kumthekar, MD
Update: 2025-03-03
Description
In this episode, Northwestern Medicine neuro-oncologist, Priya Kumthekar, MD, discusses her pioneering work in nanomedicine on an early clinical trial in individuals with the deadly brain cancer glioblastoma. The study showed an experimental spherical nucleic acid drug, developed by Northwestern University scientists, was able to penetrate the blood-brain barrier and trigger the death of tumor cells. This was the first time a nanotherapeutic has been shown to cross the blood-brain barrier. The study set a precedent at Northwestern University and has opened the door for similar studies and innovations to take place here.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
